Grateful Grants: Dr. Andrea Richardson
The V Foundation blog plans to spotlight different V Scholar Grant, Translational Grant and Designated Grant recipients in a monthly series called Grateful Grants. This month we are going to talk about one amazing scientist who is making a difference in a particular type of breast cancer research.
Dr. Andrea Richardson, who received a 2008 Translational Grant from The V Foundation, is leading a lab at the Dana-Farber Cancer Institute. Her lab has made advancements in breast cancer therapy techniques. The therapy has proven results in shrinking tumors in triple-negative breast cancer patients. Now, some of you might be asking yourself, what is triple-negative breast cancer … let me shed a little bit of light for you.
Most breast cancers are fueled by the lack of three “receptors” such as estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2). A woman with triple-negative breast cancer means that the tumor is a negative for all of these receptors.
The Triple Breast Negative Cancer Foundation states that this type of cancer generally responds to chemotherapy but that it does not respond to receptor targeted treatments. Also, the TNBC states that this cancer can more aggressive and more likely to recur. For more information on Triple Negative Breast Cancer you should check out the guide.
We are grateful that the Dr. Richardson is making advances in this type of cancer and can’t wait to see what she does in the future!